Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 47, 2013, Pages

  Benzinger, Tammie L S ^a   Blazey, Tyler ^a   Jack Jr , Clifford R ^b   Koeppe, Robert A ^c   Su, Yi ^a   Xiong, Chengjie ^d   Raichle, Marcus E ^e   Snyder, Abraham Z ^e   Ances, Beau M ^e   Bateman, Randall J ^e   Cairns, Nigel J ^f   Fagan, Anne M ^e   Goate, Alison ^g   Marcus, Daniel S ^a   Aisen, Paul S ^h   Christensen, Jon J ^a   Ercole, Lindsay ^a   Hornbeck, Russ C ^a   Farrar, Angela M ^a   Aldea, Patricia ^a   Jasielec, Mateusz S ^d   Owen, Christopher J ^a   Xie, Xianyun ^d   Mayeux, Richard ⁱ   Brickman, Adam ⁱ   McDade, Eric ^e   Klunk, William ^a   Mathis, Chester A ^j   Ringman, John ^k   Thompson, Paul M ^l   Ghetti, Bernardino ^m   Saykin, Andrew J ⁿ   Sperling, Reisa A ^o   Johnson, Keith A ^o   Salloway, Stephen ^p   Correia, Stephen ^p   Schofield, Peter R ^q,r   Masters, Colin L ^s   Rowe, Christopher ^t   Villemagne, Victor L ^t   Martins, Ralph ^u   Ourselin, Sebastien ^v   Rossor, Martin N ^v   Fox, Nick C ^v   Cash, David M ^v   Weiner, Michael W ^w   Holtzman, David M ^e   Buckles, Virginia D ^e   Moulder, Krista ^f   Morris, John C ^e   more..

^a Departments of Radiology   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d Division of Biostatistics   (United States)

^e Departments of Neurology   (United States)

^f WASHINGTON UNIVERSITY ST LOUIS   (United States)

^g WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ NewYork Presbyterian Hospital   (United States)

^j UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^k Easton Center for Alzheimer's Disease Research   (United States)

^l UNIVERSITY OF CALIFORNIA   (United States)

^m Indiana University School of Medicine ^*  (United States)

ⁿ INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o MASSACHUSETTS GENERAL HOSPITAL   (United States)

^p BROWN UNIVERSITY   (United States)

^q NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^r UNIVERSITY OF NEW SOUTH WALES   (Australia)

^s UNIVERSITY OF MELBOURNE   (Australia)

^t AUSTIN HEALTH   (Australia)

^u EDITH COWAN UNIVERSITY   (Australia)

^v UNIVERSITY COLLEGE LONDON   (United Kingdom)

^w UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; FLUORODEOXYGLUCOSE F 18; PITTSBURGH COMPOUND B;

ALZHEIMER DISEASE; ANTERIOR CINGULATE; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BRAIN CORTEX; COHORT ANALYSIS; CONTROLLED STUDY; CORTICAL THICKNESS (BRAIN); FEMALE; GENE MUTATION; GLOBUS PALLIDUS; GLUCOSE METABOLISM; GRAY MATTER; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; POSITRON EMISSION TOMOGRAPHY; POSTERIOR CINGULATE; PRECUNEUS; PRIORITY JOURNAL;

AGING; DEMENTIA; DIAN; NEURODEGENERATION; NEUROIMAGING;

ADULT; AGE OF ONSET; ALZHEIMER DISEASE; ANILINE COMPOUNDS; BIOLOGICAL MARKERS; BRAIN; CARBON RADIOISOTOPES; COHORT STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; GENES, DOMINANT; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; POSITRON-EMISSION TOMOGRAPHY; REGRESSION ANALYSIS; THIAZOLES; TIME FACTORS;

EID: 84888089112     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1317918110     Document Type: Article

References (95)

1. Goedert M, Spillantini MG (2006) A century of Alzheimer's disease. Science 314(5800- 777-781.
2. Hardy JA, Higgins GA (1992) Alzheimer's disease: The amyloid cascade hypothesis. Science 256(5054-184-185.
3. Jack CR, Jr., et al. (2010) Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 9(1-119-128.
4. Campion D, et al. (1999) Early-onset autosomal dominant Alzheimer disease: Prevalence, genetic heterogeneity, and mutation spectrum. Am J Hum Genet 65(3- 664-670.
5. Fox NC, et al. (1997) Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin 1 gene. Pedigree but not mutation specific age at onset provides evidence for a further genetic factor. Brain 120(Pt 3- 491-501.
6. Acosta-Baena N, et al. (2011) Pre-dementia clinical stages in presenilin 1 E280A familial early-onset Alzheimer's disease: A retrospective cohort study. Lancet Neurol 10(3-213-220.
7. Goate A, et al. (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349(6311-704-706.
8. Sherrington R, et al. (1995) Cloning of a gene bearing missense mutations in earlyonset familial Alzheimer's disease. Nature 375(6534-754-760.
9. Levy-Lahad E, et al. (1995) Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269(5226-973-977.
10. Houlden H, et al. (2001) A novel presenilin mutation (M233V) causing very early onset Alzheimer's disease with Lewy bodies. Neurosci Lett 313(1-2-93-95.
11. Morris JC, et al. (2012) Developing an international network for Alzheimer's research: The Dominantly Inherited Alzheimer Network. Clin Investig 2(10-975-984.
12. Bateman RJ, et al.; Dominantly Inherited Alzheimer Network (2012) Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med 367(9- 795-804.
13. Genovese CR, Lazar NA, Nichols T (2002) Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 15(4-870-878.
14. Fleisher AS, et al. (2012) Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: A cross-sectional study. Lancet Neurol 11(12-1057-1065.
15. Jack CR, Jr., et al. (2013) Tracking pathophysiological processes in Alzheimer's disease: An updated hypothetical model of dynamic biomarkers. Lancet Neurol 12(2-207-216.
16. Iseki E, et al. (1990) Morphological characteristics of senile plaques in familial Alzheimer's disease. Acta Neuropathol 80(3-227-232.
17. Koivunen J, et al. (2008) PET amyloid ligand [11C]PIB uptake shows predominantly striatal increase in variant Alzheimer's disease. Brain 131(Pt 7-1845-1853.
18. Buckner RL, et al. (2005) Molecular, structural, and functional characterization of Alzheimer's disease: Evidence for a relationship between default activity, amyloid, and memory. J Neurosci 25(34-7709-7717.
19. La Joie R, et al. (2012) Region-specific hierarchy between atrophy, hypometabolism, and β-Amyloid (Aβ) load in Alzheimer's disease dementia. J Neurosci 32(46- 16265-16273.
20. Raichle ME, et al. (2001) A default mode of brain function. Proc Natl Acad Sci USA 98(2-676-682.
21. Thompson PM, et al. (2003) Dynamics of gray matter loss in Alzheimer's disease. J Neurosci 23(3-994-1005.
22. Whitwell JL, et al. (2007) 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease. Brain 130(Pt 7-1777-1786.
23. Förster S, et al. (2012) Regional expansion of hypometabolism in Alzheimer's disease follows amyloid deposition with temporal delay. Biol Psychiatry 71(9-792-797.
24. Villain N, et al.; AIBL Research Group (2012) Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: A voxelwise PiB-PET longitudinal study. Brain 135(Pt 7-2126-2139.
25. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82(4-239-259.
26. Price JL, Morris JC (1999) Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann Neurol 45(3-358-368.
27. Reiman EM, et al. (2004) Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc Natl Acad Sci USA 101(1-284-289.
28. Oh H, Habeck C, Madison C, Jagust W (2012) Covarying alterations in Aβ deposition, glucose metabolism, and gray matter volume in cognitively normal elderly. Hum Brain Mapp, 10.1002/hbm.22173.
29. Cohen AD, et al. (2009) Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: An example of brain reserve. J Neurosci 29(47-14770-14778.
30. Cirrito JR, et al. (2005) Synaptic activity regulates interstitial fluid amyloid-β levels in vivo. Neuron 48(6-913-922.
31. Reiman EM, et al. (2012) Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: A case-control study. Lancet Neurol 11(12-1048-1056.
32. Potter R et al. (2013) Increased in vivo amyloid- 42 production, exchange, and loss in presenilin mutation carriers. Sci Transl Med 5(189-189ra77.
33. Sabuncu MR, et al.; Alzheimer's Disease Neuroimaging Initiative (2011) The dynamics of cortical and hippocampal atrophy in Alzheimer disease. Arch Neurol 68(8- 1040-1048.
34. Caroli A, Frisoni GB; Alzheimer's Disease Neuroimaging Initiative (2010) The dynamics of Alzheimer's disease biomarkers in the Alzheimer's Disease Neuroimaging Initiative cohort. Neurobiol Aging 31(8-1263-1274.
35. Jack CR et al. (2012) Shapes of the trajectories of 5 major biomarkers of Alzheimer disease. Arch Neurol 69(7-856-867.
36. Jack CR, Jr., et al. (2013) Brain β-Amyloid load approaches a plateau. Neurology 80(10- 890-896.
37. Villemagne VL, et al.; Australian Imaging Biomarkers and Lifestyle (AIBL) Research Group (2013) Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: A prospective cohort study. Lancet Neurol 12(4- 357-367.
38. Su Y, et al. (2012) Noninvasive estimation of the arterial input function in positron emission tomography imaging of cerebral blood flow. J Cereb Blood Flow Metab 33(1-115-121.
39. Salat DH, et al. (2009) Age-Associated alterations in cortical gray and white matter signal intensity and gray to white matter contrast. Neuroimage 48(1-21-28.
40. Salat DH, et al. (2011) Hippocampal degeneration is associated with temporal and limbic gray matter/white matter tissue contrast in Alzheimer's disease. Neuroimage 54(3-1795-1802.
41. Salat DH, et al. (2004) Thinning of the cerebral cortex in aging. Cereb Cortex 14(7- 721-730.
42. Fjell AM, et al. (2009) High consistency of regional cortical thinning in aging across multiple samples. Cereb Cortex 19(9-2001-2012.
43. Fjell AM, et al.; Alzheimer Disease Neuroimaging Initiative (2012) Accelerating cortical thinning: Unique to dementia or universal in aging? Cereb Cortex, 23236213.
44. Abe O, et al. (2008) Aging in the CNS: Comparison of gray/white matter volume and diffusion tensor data. Neurobiol Aging 29(1-102-116.
45. Raz N, et al. (2004) Aging, sexual dimorphism, and hemispheric asymmetry of the cerebral cortex: Replicability of regional differences in volume. Neurobiol Aging 25(3-377-396.
46. Zhou J, et al. (2010) Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease. Brain 133(Pt 5-1352-1367.
47. Brier MR, et al. (2012) Loss of intranetwork and internetwork resting state functional connections with Alzheimer's disease progression. J Neurosci 32(26-8890-8899.
48. Rousset OG, Ma Y, Evans AC (1998) Correction for partial volume effects in PET: Principle and validation. J Nucl Med 39(5-904-911.
49. Frouin V, Comtat C, Reilhac A, Grégoire M-C (2002) Correction of partial-volume effect for PET striatal imaging: Fast implementation and study of robustness. J Nucl Med 43(12-1715-1726.
50. Zaidi H, Ruest T, Schoenahl F, Montandon M-L (2006) Comparative assessment of statistical brain MR image segmentation algorithms and their impact on partial volume correction in PET. Neuroimage 32(4-1591-1607.
51. Fortea J, et al. (2010) Increased cortical thickness and caudate volume precede atrophy in PSEN1 mutation carriers. J Alzheimers Dis 22(3-909-922.
52. Lee GJ, et al. (2013) Regional brain volume differences in symptomatic and presymptomatic carriers of familial Alzheimer's disease mutations. J Neurol Neurosurg Psychiatry 84(2-154-162.
53. Fischl B, et al. (2002) Whole brain segmentation: Automated labeling of neuroanatomical structures in the human brain. Neuron 33(3-341-355.
54. Klunk WE, et al. (2007) Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. J Neurosci 27(23-6174-6184.
55. Villemagne VL, Ataka S, Mizuno T (2009) High striatal amyloid β-peptide deposition across different autosomal Alzheimer disease mutation types. Arch Neurol 66(12- 1537-1544.
56. Knight WD, et al. (2011) Carbon-11-Pittsburgh compound B positron emission tomography imaging of amyloid deposition in presenilin 1 mutation carriers. Brain 134(Pt 1-293-300.
57. Perani D, Grassi F, Sorbi S (1997) PET study in subjects from two Italian FAD families with APP717 Val to Ileu mutation. Eur J Neurol 4(3-214-220.
58. Kennedy AM, et al. (1995) Chromosome 14 linked familial Alzheimer's disease. A clinico-pathological study of a single pedigree. Brain 118(Pt 1-185-205.
59. Polinsky RJ, et al. (1987) Dominantly inherited Alzheimer's disease: Cerebral glucose metabolism. J Neurol Neurosurg Psychiatry 50(6-752-757.
60. Mosconi L, Sorbi S, de Leon MJ, Li Y (2006) Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease. J Nucl Med 47(11- 1778-1786.
61. Gregory GC, Macdonald V, Schofield PR, Kril JJ, Halliday GM (2006) Differences in regional brain atrophy in genetic forms of Alzheimer's disease. Neurobiol Aging 27(3-387-393.
62. Ginestroni A, et al. (2009) Early structural changes in individuals at risk of familial Alzheimer's disease: A volumetry and magnetization transfer MR imaging study. J Neurol 256(6-925-932.
63. Schott JM, et al. (2003) Assessing the onset of structural change in familial Alzheimer's disease. Ann Neurol 53(2-181-188.
64. Knight WD, et al. (2011) Acceleration of cortical thinning in familial Alzheimer's disease. Neurobiol Aging 32(10-1765-1773.
65. Apostolova LG, et al. (2011) Cortical and hippocampal atrophy in patients with autosomal dominant familial Alzheimer's disease. Dement Geriatr Cogn Disord 32(2- 118-125.
66. Fox NC, Warrington EK, Stevens JM (1996) Atrophy of the hippocampal formation in early familial Alzheimer's disease. Ann N Y Acad Sci 777:226-232.
67. Fox NC, et al. (1996) Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study. Brain 119(Pt 6-2001-2007.
68. Ridha BH, et al. (2006) Tracking atrophy progression in familial Alzheimer's disease: A serial MRI study. Lancet Neurol 5(10-828-834.
69. Ostrowitzki S, et al. (2012) Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab. Arch Neurol 69(2-198-207.
70. Kohannim O, et al.; Alzheimer's Disease Neuroimaging Initiative (2010) Boosting power for clinical trials using classifiers based on multiple biomarkers. Neurobiol Aging 31(8-1429-1442.
71. Roe CM, et al. (2011) Improving CSF biomarker accuracy in predicting prevalent and incident Alzheimer disease. Neurology 76(6-501-510.
72. Zhang D, Wang Y, Zhou L, Yuan H, Shen D; Alzheimer's Disease Neuroimaging Initiative (2011) Multimodal classification of Alzheimer's disease and mild cognitive impairment. Neuroimage 55(3-856-867.
73. Hinrichs C, Singh V, Xu G, Johnson SC, Initiative TADN; Alzheimers Disease Neuroimaging Initiative (2011) Predictive markers for AD in a multi-modality framework: An analysis of MCI progression in the ADNI population. Neuroimage 55(2-574-589.
74. Morris JC (1993) The Clinical Dementia Rating (CDR- Current version and scoring rules. Neurology 43(11-2412-2414.
75. Cruchaga C, et al.; NIA-LOAD/NCRAD Family Study Consortium (2012) Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families. PLoS ONE 7(2-e31039.
76. Jack CR, Jr., et al. (2008) The Alzheimer's disease neuroimaging initiative (ADNI- MRI methods. J Magn Reson Imaging 27(4-685-691.
77. Jack CR, Jr., et al. (2010) Update on the Magnetic Resonance Imaging Core of the Alzheimer's Disease Neuroimaging Initiative. Alzheimer's Dementia 6(3-212-220.
78. Fischl B (2012) FreeSurfer. Neuroimage 62(2-774-781.
79. Desikan RS, et al. (2006) An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 31(3- 968-980.
80. Jack CR, et al. (1989) Anterior temporal lobes and hippocampal formations: Normative volumetric measurements from MR images in young adults. 172(2-549-554.
81. Fischl B, Dale AM (2000) Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci USA 97(20-11050-11055.
82. Rowland DJ, Garbow JR, Laforest R, Snyder AZ (2005) Registration of [18F]FDG microPET and small-Animal MRI. Nucl Med Biol 32(6-567-572.
83. Eisenstein SA, et al. (2012) Characterization of extrastriatal D2 in vivo specific binding of [F](N-methyl)benperidol using PET. Synapse 66(9-770-780.
84. Joshi A, Koeppe RA, Fessler JA (2009) Reducing between scanner differences in multicenter PET studies. NeuroImage 46(1-154-159.
85. Lippa CF, et al. (1996) Familial and sporadic Alzheimer's disease: neuropathology cannot exclude a final common pathway. Neurology 46(2-406-412.
86. Mann DMA, Pickering-Brown SM, Takeuchi A, Iwatsubo T; Members of the Familial Alzheimer's Disease Pathology Study Group (2001) Amyloid angiopathy and variability in amyloid β deposition is determined by mutation position in presenilin-1- linked Alzheimer's disease. Am J Pathol 158(6-2165-2175.
87. Edison P, et al. (2012) Can target-To-pons ratio be used as a reliable method for the analysis of [11C]PIB brain scans? Neuroimage 60(3-1716-1723.
88. Minoshima S, Frey KA, Foster NL, Kuhl DE (1995) Preserved pontine glucose metabolism in Alzheimer disease: A reference region for functional brain image (PET) analysis. J Comput Assist Tomogr 19(4-541-547.
89. Pinheiro J, Bates D, DebRoy S, Sarkar D, Team TRDC (2012) Linear and nonlinear mixed effects models. R package version 3, pp 57.
90. R Development Core Team (2011) R: A Language and Environment for Statistical Computing (R Foundation, Vienna). Available at www.R-project.org/. Accessed February 5, 2013.
91. Cleveland WS (1979) Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc 74(368-829-836.
92. Ramachandran P, Varoquaux G (2011) Mayavi: 3D visualization of scientific data. Comput Sci Eng 13(2-40-51.
93. Wickham H (2009) ggplot2: Elegant Graphics for Data Analysis (Springer, Dordrecht, The Netherlands).
94. Laird NM, Ware JH (1982) Random-effects models for longitudinal data. Biometrics 38(4-963-974.
95. Kenward MG, Roger JH (1997) Small sample inference for fixed effects from restricted maximum likelihood. Biometrics 53(3-983-997.